Home / Healthcare / Precision Medicine Market By Applications (Oncology, Cardiovascular Diseases, Central Nervous System, Infectious Diseases) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2023

Precision Medicine Market By Applications (Oncology, Cardiovascular Diseases, Central Nervous System, Infectious Diseases) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2023


Published: Jul 2016

This report titled precision medicine market studies various technology type, application type and geographical scenario. In July 2016, The White House announced that it is giving out USD 55.0 million to a collection of hospitals and companies to uncover links between a person’s genome and disease and built a genetic database of initially at least 1 million Americans. Market experts suggest that the proposed initiative has two main components: a near-term focus on cancers and a longer-term aim to generate knowledge applicable to the whole range of health and disease. Both components are now within the reach because of advances in basic research, including molecular biology, genomics, and bioinformatics.

For the purpose of this study, the global precision medicine market on the basis of technology type is segmented into companion diagnostics, gene sequencing, drug discovery, big data analytics, bio informatics & 3D printing. Market size estimates and forecast for these segments for the period 2013 to 2022 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2016 to 2022, considering 2015 as the base year.

For the purpose of this study, the global precision medicine market on the basis of application type is segmented into oncology, cardiovascular diseases, central nervous system, infectious diseases & others. Market size estimates and forecast for these segments for the period 2013 to 2022 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2016 to 2022, considering 2015 as the base year.

The precision medicine market has been geographically categorized into major regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further split to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, Brazil, and GCC countries. Market size and forecast for these segments during 2013 to 2022 and their CAGRs for the period 2016 to 2022 are provided in this report.

The major key players profiled in the precision medicine market are on the basis of various characteristics such as business description, financial health and budget allocation, product portfolio, and news coverage. The key players profiled in this report are Biocrates Life Sciences, Nanostring Technologies, Tepnel Pharma Services, Intomics, Ferrer InCode, Abbott Laboratories, Almac Group, Ltd., bioMérieux SA, Covance, Silicon Biosystems (now part of the Menarini Group), Pfizer, Eagle Genomics, Source Precision Medicine, Inc., Laboratory Corporation of America Holdings, Medtronics, Novartis, Qiagen, Quest Diagnostics, Roche Holding, Teva Pharmaceuticals, and others.

TABLE 1 Market Competition Assessment: Precision Medicine , by Key Players 25
TABLE 2 Global Precision Medicine Market, by Technology Type, 2013-2023 (USD Mn) 28
TABLE 3 Global Precision Medicine Market, by Applications, 2013-2023 (USD Mn) 37
TABLE 4 Global Precision Medicine Market, by Geography, 2013 – 2023 (USD Mn) 43
TABLE 5 Biocrates Life Sciences: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 51
TABLE 6 Nanostring Technologies: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 52
TABLE 7 Tepnel Pharma Services: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 53
TABLE 8 Intomics, Ferrer InCode: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 54
TABLE 9 Abbott Laboratories: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 55
TABLE 10 Almac Group, Ltd.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 57
TABLE 11 bioMérieux SA: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 58
TABLE 12 Covance: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 59
TABLE 13 Menarini Group: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 60
TABLE 14 Pfizer: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 61
TABLE 15 Eagle Genomics, Source Precision Medicine, Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 63
TABLE 16 Laboratory Corporation of America Holdings: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 64
TABLE 17 Medtronics: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 65
TABLE 18 Novartis: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 66
TABLE 19 Qiagen: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 67
TABLE 20 Quest Diagnostics: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 67
TABLE 21 Roche Holding: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 67
TABLE 22 Teva Pharmaceuticals: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 68

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +